Brief: Visiox Pharmaceuticals To Be Listed On Nasdaq Via A Business Combination With PowerUp Acquisition
27/12/2023 13:38
Dec 27 (Reuters) - PowerUp Acquisition Corp PWUP.O :
* VISIOX PHARMACEUTICALS, INC., A COMMERCIAL-STAGE
BIOPHARMACEUTICAL COMPANY TO BE LISTED ON NASDAQ THROUGH A
BUSINESS COMBINATION WITH POWERUP ACQUISITION CORP.
* POWERUP ACQUISITION -EXECUTION OF DEFINITIVE AGREEMENT FOR
BUSINESS COMBINATION,VISIOX BECOMING PUBLICLY TRADED COMPANY ON
NASDAQ CAPITAL MARKET
* POWERUP ACQUISITION CORP: UPON CLOSING OF TRANSACTION,
VISIOX
WILL CONTINUE TO BE LED BY CURRENT CEO, RYAN BLEEKS
* POWERUP ACQUISITION CORP - BUSINESS COMBINATION IS
EXPECTED TO
CLOSE IN Q1 OF 2024
* POWERUP ACQUISITION: UPON CLOSING, COMBINED CO TO BE NAMED
VISIOX HOLDINGS, INC. WITH COMMON STOCK EXPECTED TO BE LISTED ON
NASDAQ UNDER TICKER VSXP
Source text for Eikon: ID:nGNXCs2Rl
Further company coverage: PWUP.O
((Reuters.Briefs@thomsonreuters.com;))